SIMPONI ® is a treatment that can help control inflammation in your body—the source of ulcerative colitis (UC) symptoms. SIMPONI ® is used for adults with moderately to severely active ulcerative …

Jan 3, 2007 · SIMPONI is indicated in adult patients with moderately to severely active ulcerative colitis who have demonstrated corticosteroid dependence or who have had an inadequate response to or …

For adults with moderately to severely active ulcerative colitis (UC) SIMPONI® Offers an Injection Experience to Consider for Your Patients 1,2

Mar 28, 2025 · Simponi (golimumab) is a brand-name subcutaneous injection that’s prescribed for ulcerative colitis. This article covers topics such as side effects, dosage, and how Simponi works.

Oct 10, 2025 · Simponi can also be given with steroid medicines to help with some symptoms, to get the ulcerative colitis under control and keep it under control, and to improve the way the lining of your …

Oct 29, 2025 · For patients with RA, PsA, or AS, corticosteroids, non-biologic DMARDs, and/or NSAIDs may be continued during treatment with SIMPONI. 2.3 Recommended Dosage for Moderately to …

Oct 15, 2025 · Ulcerative colitis (UC) Simponi is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy …

The safety and effectiveness of SIMPONI for the treatment of moderately to severely active ulcerative colitis have been established in pediatric patients weighing at least 15 kg.

Simponi (golimumab) for ulcerative colitis Golimumab (brand name Simponi) is an injectable biologic medication licensed to treat adults with moderate to severe ulcerative colitis. Find out more about it …

Medscape - Rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis dosing for Simponi, Simponi Aria (golimumab), frequency-based adverse effects, comprehensive interactions, contraindications, …